| Swoop Holdings Limited (SWP) ORDINARY FULLY PAID |
Communication Services |
$31 |
SWP 1HFY25 Results Announcement
|
27 Feb 2025 8:30AM |
$0.165 |
$0.100 |
fallen by
39.39%
|
|
SWP - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue of $45.8 million, up 5% YoY.
- Underlying Recurring Revenue organic growth of 15%.
- Underlying EBITDA of $7.3 million.
- Core Business EBITDA is up 12% on 1H FY24.
- 24% increase in total subscriber numbers from December 2023.
- Opex as a percentage of Revenue is now 20%, a reduction of 15% over the last 3 years.
- Positive NPAT result of $0.1 million, a $1.1m improvement on 1H FY24.
- Completed the divestment of the wholesale voice business in July 2024 for $8.8 million.
- $15.5 million of available funding as at 31 December 2024.
- Signed a 3-year agreement to provide wholesale internet services to Flip.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Swoop Holdings Limited (SWP) ORDINARY FULLY PAID |
Communication Services |
$31 |
SWP 1HFY25 Investor Briefing
|
27 Feb 2025 8:29AM |
$0.165 |
$0.100 |
fallen by
39.39%
|
|
SWP - Price-sensitive ASX Announcement
Full Release
Key Points
- 1H FY25 revenue of $45.8m, up 5% from 1H FY24.
- Underlying recurring revenue organic growth of 15%.
- Subscriber numbers increased by 24% to 200,726.
- Key customer contract worth up to $36m over 22 years.
- Divested wholesale voice business for $8.8m.
- New fibre infrastructure planned in Greater Melbourne.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Qantas Airways Limited (QAN) ORDINARY FULLY PAID |
Industrials |
$15,601 |
Qantas Group HY25 Results ASX and Media Release
|
27 Feb 2025 8:29AM |
$8.890 |
$10.310 |
risen by
15.97%
|
|
QAN - Price-sensitive ASX Announcement
Full Release
Key Points
- Underlying Profit Before Tax of $1.39 billion, up 11%
- Statutory Profit After Tax of $923 million, up 6%
- Customer Net Promoter Score improved for Qantas and Jetstar
- 11 new aircraft added in the first half of FY25
- Return to dividends with $250 million base and $150 million special dividends
- Increased focus on customer experience enhancements
- Strong growth in Qantas Loyalty with a 11% rise in active members
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Coles Group Limited (COL) ORDINARY FULLY PAID |
Consumer Staple |
$28,802 |
2025 Half Year Results Release
|
27 Feb 2025 8:28AM |
$19.690 |
$21.460 |
risen by
8.99%
|
|
COL - Price-sensitive ASX Announcement
Full Release
Key Points
- Group sales increased by 3.7% to $23.035 billion.
- Underlying EBIT growth of 8.9% to $1,209 million.
- Supermarkets sales revenue rose by 4.3% due to strategic initiatives.
- Strong eCommerce sales growth of 22.6% in Supermarkets.
- Interim dividend declared at 37 cents per share, fully franked.
- Investment in new distribution centers to enhance supply chain capacity.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Knosys Limited (KNO) ORDINARY FULLY PAID |
Information Technology |
$5 |
Half Yearly Report and Accounts
|
27 Feb 2025 8:28AM |
$0.041 |
$0.021 |
fallen by
48.78%
|
|
KNO - Price-sensitive ASX Announcement
Full Release
Key Points
- New contract signed with the Office of the Director of Public Prosecutions in WA valued at up to $985k.
- Renewals of contracts with large enterprise clients exceeding $3.6 million.
- Record Annual Recurring Revenue (ARR) of $9.7 million as of January 2025.
- Investment in development personnel for library-tech product development.
- Launch of a mobile library app planned for March 2025.
- Total revenue of $5.4 million, a slight increase from the prior year.
- Net loss of $0.3 million attributed to high investment and operational costs.
- Operational cash outflow of $0.7 million due to timing of fee receipts.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,066 |
2024 Corporate Governance Statement and Appendix 4G
|
27 Feb 2025 8:27AM |
$5.070 |
$4.870 |
fallen by
3.94%
|
|
| Raiden Resources Limited (RDN) ORDINARY FULLY PAID |
Materials |
$17 |
New discovery and extensions to Ni-Cu Mineralisation
|
27 Feb 2025 8:27AM |
$0.006 |
$0.005 |
fallen by
16.67%
|
|
RDN - Price-sensitive ASX Announcement
Full Release
Key Points
- Raiden Resources reported new discoveries and extensions to Ni-Cu mineralization at Mt Sholl.
- Ten reverse circulation drill holes were completed, confirming significant mineralization at depth.
- Notable drill results include 63m @ 0.43% Ni+Cu at A1 deposit and 103m @ 0.22% Ni+Cu at B2 deposit.
- The drilling has also identified new targets in the 'Keel' area.
- All drilling activities were financed by First Quantum Minerals as part of a memorandum of understanding.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Brambles Limited (BXB) ORDINARY FULLY PAID |
Industrials |
$31,316 |
Notification of cessation of securities - BXB
|
27 Feb 2025 8:27AM |
$20.980 |
$23.060 |
risen by
9.91%
|
|
| Ramsay Health Care Limited (RHC) ORDINARY FULLY PAID |
Health Care |
$7,950 |
Update - Dividend/Distribution - RHCPA
|
27 Feb 2025 8:26AM |
$33.870 |
$34.440 |
risen by
1.68%
|
|
| Qantas Airways Limited (QAN) ORDINARY FULLY PAID |
Industrials |
$15,601 |
Dividend/Distribution - QAN
|
27 Feb 2025 8:26AM |
$8.890 |
$10.310 |
risen by
15.97%
|
|
| Intelligent Monitoring Group Limited (IMB) ORDINARY FULLY PAID |
Industrials |
$276 |
IMB Results Release and Q&A Invitation
|
27 Feb 2025 8:25AM |
$0.535 |
$0.670 |
risen by
25.23%
|
|
| Alcidion Group Limited (ALC) ORDINARY FULLY PAID |
Health Care |
$134 |
H1 FY25 Results Presentation
|
27 Feb 2025 8:25AM |
$0.090 |
$0.100 |
risen by
11.11%
|
|
ALC - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue of $17.6 million, down 7% compared to H1 FY24.
- Achieved a positive underlying EBITDA of $0.5 million.
- Total contracted revenue for FY25 is $39.5 million.
- New contracts include significant deals with Hywel Dda and North Cumbria.
- Confident of delivering positive EBITDA and cash flow for the full year FY25.
- Strong momentum building for solutions across existing markets.
- Cash balance of $7.7 million and no debt as of 31 December 2024.
- Focus on expanding digital healthcare solutions in the UK and Australia.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,066 |
2024 Annual Report
|
27 Feb 2025 8:24AM |
$5.070 |
$4.870 |
fallen by
3.94%
|
|
| Qantas Airways Limited (QAN) ORDINARY FULLY PAID |
Industrials |
$15,601 |
Qantas Group HY25 Appendix 4D and Interim Financial Report
|
27 Feb 2025 8:24AM |
$8.890 |
$10.310 |
risen by
15.97%
|
|
QAN - Price-sensitive ASX Announcement
Full Release
Key Points
- Underlying profit before tax increased by $140 million compared to the previous year.
- Statutory profit after tax rose to $923 million.
- Total revenue for the half-year was $12,129 million, up 9.0% from the previous year.
- Domestic operations reported an underlying EBIT of $647 million.
- International operations performed strongly with an underlying EBIT of $327 million.
- Strong demand in corporate and leisure travel supported revenue growth.
- The Group maintained focus on fleet renewal and customer experience enhancements.
- The Board announced a base dividend of $250 million and an additional special dividend of $150 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Coles Group Limited (COL) ORDINARY FULLY PAID |
Consumer Staple |
$28,802 |
Dividend/Distribution - COL
|
27 Feb 2025 8:24AM |
$19.690 |
$21.460 |
risen by
8.99%
|
|
| Pacific Smiles Group Limited (PSQ) ORDINARY FULLY PAID |
Health Care |
$352 |
PSQ FY25 Half Year Results Presentation
|
27 Feb 2025 8:23AM |
$1.960 |
$2.180 |
risen by
11.22%
|
|
PSQ - Price-sensitive ASX Announcement
Full Release
Key Points
- 9.0% increase in patient fees year-over-year to $160.3 million
- Underlying net profit after tax increased by 51.5% to $6.7 million
- Strong operational efficiencies led to improved financial metrics
- Declining cancellation rates indicating better patient communication
- Healthy net cash position of $8.1 million, debt-free
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Alcidion Group Limited (ALC) ORDINARY FULLY PAID |
Health Care |
$134 |
H1 FY25 Results Release
|
27 Feb 2025 8:23AM |
$0.090 |
$0.100 |
risen by
11.11%
|
|
ALC - Price-sensitive ASX Announcement
Full Release
Key Points
- H1 FY25 revenue of $17.6 million, a 7% decrease from pcp.
- Underlying EBITDA improved to $0.5 million, up $3.3 million from last year.
- New contracts totaling $61.3 million year-to-date, including a significant contract in Wales.
- Contracted revenue for FY25 estimated to be at least $39.5 million.
- Positive EBITDA and cash flow results anticipated for full year FY25.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Pacific Smiles Group Limited (PSQ) ORDINARY FULLY PAID |
Health Care |
$352 |
PSQ announces Half Year Results to 31 December 2024
|
27 Feb 2025 8:23AM |
$1.960 |
$2.180 |
risen by
11.22%
|
|
PSQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Patient Fees of $160.3m, up 9.0% vs pcp
- Group Revenue of $99.0m, up 10.0% vs pcp
- Underlying EBITDA of $16.3m, up 16.8% vs pcp
- Underlying NPAT of $6.7m, compared with $4.4m in the pcp
- Total Pacific Smiles centres of 126, with two closures in 1H25
- Capital expenditure for the period of $3.2m, higher than the $1.8m reported in 1H24
- No interim dividend declared for FY25
- Patient satisfaction remains high with a net promoter score of 90
- Full year guidance re-affirmed for patient fees in the range of $310m to $318m
- Management focused on growth and maintaining a positive culture
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,066 |
2024 Full Year Investor Reference Pack
|
27 Feb 2025 8:22AM |
$5.070 |
$4.870 |
fallen by
3.94%
|
|
ALX - Price-sensitive ASX Announcement
Full Release
Key Points
- The Investor Reference Pack supplements the Financial Report of Atlas Arteria for the year ended 31 December 2024.
- Atlas Arteria operates toll roads in France, Germany, and the US, with an average portfolio concession life of around 18 years.
- The company has a 30.82% interest in the APRR toll road group in France.
- Atlas Arteria owns a 100% economic interest in the Dulles Greenway and the Warnow Tunnel.
- The APRR and AREA tolls escalate annually based on French CPI and government agreements.
- The Pack provides a detailed analysis of each business within the Atlas Arteria portfolio.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ramsay Health Care Limited (RHC) ORDINARY FULLY PAID |
Health Care |
$7,950 |
Dividend/Distribution - RHC
|
27 Feb 2025 8:22AM |
$33.870 |
$34.440 |
risen by
1.68%
|
|
| Alcidion Group Limited (ALC) ORDINARY FULLY PAID |
Health Care |
$134 |
H1 FY25 Appendix 4D and Half Year Report
|
27 Feb 2025 8:22AM |
$0.090 |
$0.100 |
risen by
11.11%
|
|
ALC - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue of $17,638K, a 7.5% decrease from the previous year.
- Gross profit of $15,366K, down 8.1% from the prior corresponding period.
- Loss after income tax improved to $889K from a loss of $4,336K.
- Underlying EBITDA profit of $541K, improving from a loss of $2,788K.
- Strategic restructuring has led to decreased employee benefits expenses.
- Alcidion signed significant new contracts expected to enhance future revenues.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mach7 Technologies Limited (M7T) ORDINARY FULLY PAID |
Health Care |
$134 |
First Half FY25 Result Presentation
|
27 Feb 2025 8:21AM |
$0.440 |
$0.570 |
risen by
29.55%
|
|
M7T - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue of A$17.7M, up 33% on prior corresponding period.
- Recurring revenue of A$12.6M, up 28%, accounting for 71% of total revenue.
- Operating expenses increased by 15% to A$15.8M.
- Positive EBITDA of A$0.8M, an improvement from the loss of A$1.6M in H1 FY24.
- Cash balance of A$23.6M at 31 December 2024, up 4% from the previous year.
- No debt reported by Mach7 Technologies.
- On-market share buy-back program announced for up to A$5M expected to commence in March 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Coles Group Limited (COL) ORDINARY FULLY PAID |
Consumer Staple |
$28,802 |
Half Yearly Report and Accounts
|
27 Feb 2025 8:21AM |
$19.690 |
$21.460 |
risen by
8.99%
|
|
COL - Price-sensitive ASX Announcement
Full Release
Key Points
- Sales revenue increased by 3.7% to $23,106 million.
- Earnings before interest and tax (EBIT) rose by 2.4% to $1,082 million.
- Net profit attributable to members decreased by 2.2% to $576 million.
- An interim dividend of 37.0 cents per share has been declared.
- The payment date for the interim dividend is March 27, 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Mach7 Technologies Limited (M7T) ORDINARY FULLY PAID |
Health Care |
$134 |
First Half FY25 Result
|
27 Feb 2025 8:20AM |
$0.440 |
$0.570 |
risen by
29.55%
|
|
M7T - Price-sensitive ASX Announcement
Full Release
Key Points
- CARR of A$31.8M at 31 Dec 2024, up 19% on PCP
- ARR run rate of A$25.1M at 31 Dec 2024, up 35% on PCP
- Total revenue of A$17.7M, up 33% on PCP
- OPEX growth of 15% on PCP
- Cash of A$23.6M at 31 Dec 2024, up 4% on PCP
- On-market share buy-back of up to A$5M expected to commence on 3 Mar 2025
- Mach7 reaffirms FY25 guidance for 15-25% growth in CARR and revenue on PCP
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Atlas Arteria (ALX) FPO STAP US PROHIBITED EXCLUDING QIB/QP |
Industrials |
$7,066 |
2024 Full Year Results Presentation
|
27 Feb 2025 8:20AM |
$5.070 |
$4.870 |
fallen by
3.94%
|
|
ALX - Price-sensitive ASX Announcement
Full Release
Key Points
- Net profit after tax: $275.3m, +7.4% vs 2023
- Proportional toll revenue: $1,838.7m, +5.1% vs 2023
- Proportional EBITDA: $1,381.1m, +0.4% vs 2023
- Operating free cash flow: $527.1m, +16.0% vs 2023
- Distributions per security: 40.0 cps, unchanged from 2023
- Traffic increased on Dulles Greenway by 5.9% and Warnow Tunnel by 5.6%
- Toll revenue for Warnow Tunnel rose by 14.2%
- Toll revenue for Dulles Greenway increased by 6.9%
- APRR experienced a 0.4% increase in traffic overall
- Execution of capital management initiatives to optimize free cash flow.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
